These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 24342806)

  • 1. Prostaglandin E2-EP3 signaling induces inflammatory swelling by mast cell activation.
    Morimoto K; Shirata N; Taketomi Y; Tsuchiya S; Segi-Nishida E; Inazumi T; Kabashima K; Tanaka S; Murakami M; Narumiya S; Sugimoto Y
    J Immunol; 2014 Feb; 192(3):1130-7. PubMed ID: 24342806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-Stimulation of Purinergic P2X4 and Prostanoid EP3 Receptors Triggers Synergistic Degranulation in Murine Mast Cells.
    Yoshida K; Tajima M; Nagano T; Obayashi K; Ito M; Yamamoto K; Matsuoka I
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31627451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation.
    Kay LJ; Yeo WW; Peachell PT
    Br J Pharmacol; 2006 Apr; 147(7):707-13. PubMed ID: 16432506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukotriene D4 and prostaglandin E2 signals synergize and potentiate vascular inflammation in a mast cell-dependent manner through cysteinyl leukotriene receptor 1 and E-prostanoid receptor 3.
    Kondeti V; Al-Azzam N; Duah E; Thodeti CK; Boyce JA; Paruchuri S
    J Allergy Clin Immunol; 2016 Jan; 137(1):289-298. PubMed ID: 26255103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptors and signaling mechanisms required for prostaglandin E2-mediated regulation of mast cell degranulation and IL-6 production.
    Nguyen M; Solle M; Audoly LP; Tilley SL; Stock JL; McNeish JD; Coffman TM; Dombrowicz D; Koller BH
    J Immunol; 2002 Oct; 169(8):4586-93. PubMed ID: 12370397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin E potentiates the immunologically stimulated histamine release from human peripheral blood-derived mast cells through EP1/EP3 receptors.
    Wang XS; Lau HY
    Allergy; 2006 Apr; 61(4):503-6. PubMed ID: 16512814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential role of EP3 subtype in prostaglandin E2-induced adhesion of mouse cultured and peritoneal mast cells to the Arg-Gly-Asp-enriched matrix.
    Sakanaka M; Tanaka S; Sugimoto Y; Ichikawa A
    Am J Physiol Cell Physiol; 2008 Nov; 295(5):C1427-33. PubMed ID: 18815228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological and molecular characterization of the mechanisms involved in prostaglandin E2-induced mouse paw edema.
    Claudino RF; Kassuya CA; Ferreira J; Calixto JB
    J Pharmacol Exp Ther; 2006 Aug; 318(2):611-8. PubMed ID: 16644903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin E2-prostanoid EP3 signal induces vascular contraction via nPKC and ROCK activation in rat mesenteric artery.
    Kobayashi K; Murata T; Hori M; Ozaki H
    Eur J Pharmacol; 2011 Jun; 660(2-3):375-80. PubMed ID: 21463619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin E2 selectively enhances the IgE-mediated production of IL-6 and granulocyte-macrophage colony-stimulating factor by mast cells through an EP1/EP3-dependent mechanism.
    Gomi K; Zhu FG; Marshall JS
    J Immunol; 2000 Dec; 165(11):6545-52. PubMed ID: 11086097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravital microscopic studies on acute mast cell-dependent inflammation.
    Raud J
    Acta Physiol Scand Suppl; 1989; 578():1-58. PubMed ID: 2471389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-induced reprogramming of mast cell degranulation.
    Nguyen M; Pace AJ; Koller BH
    J Immunol; 2005 Nov; 175(9):5701-7. PubMed ID: 16237060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nerve growth factor modifies the expression of inflammatory cytokines by mast cells via a prostanoid-dependent mechanism.
    Marshall JS; Gomi K; Blennerhassett MG; Bienenstock J
    J Immunol; 1999 Apr; 162(7):4271-6. PubMed ID: 10201958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PGE₂ promotes apoptosis induced by cytokine deprivation through EP3 receptor and induces Bim in mouse mast cells.
    Kovarova M; Koller BH
    PLoS One; 2014; 9(7):e102948. PubMed ID: 25054560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct PGE2-responder and non-responder phenotypes in human mast cell populations: "all or nothing" enhancement of antigen-dependent mediator release.
    Kuehn HS; Jung MY; Beaven MA; Metcalfe DD; Gilfillan AM
    Immunol Lett; 2011 Dec; 141(1):45-54. PubMed ID: 21798286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the EP receptor subtype that mediates the inhibitory effects of prostaglandin E2 on IgE-dependent secretion from human lung mast cells.
    Kay LJ; Gilbert M; Pullen N; Skerratt S; Farrington J; Seward EP; Peachell PT
    Clin Exp Allergy; 2013 Jul; 43(7):741-51. PubMed ID: 23786281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of selective prostaglandin E2 (PGE2) receptor agonists as therapeutic agents for the treatment of asthma.
    Chung KF
    Sci STKE; 2005 Sep; 2005(303):pe47. PubMed ID: 16189372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin E2-induced inflammation: Relevance of prostaglandin E receptors.
    Kawahara K; Hohjoh H; Inazumi T; Tsuchiya S; Sugimoto Y
    Biochim Biophys Acta; 2015 Apr; 1851(4):414-21. PubMed ID: 25038274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects.
    Theoharides TC; Singh LK; Boucher W; Pang X; Letourneau R; Webster E; Chrousos G
    Endocrinology; 1998 Jan; 139(1):403-13. PubMed ID: 9421440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple roles of the PGE2 -EP receptor signal in vascular permeability.
    Omori K; Kida T; Hori M; Ozaki H; Murata T
    Br J Pharmacol; 2014 Nov; 171(21):4879-89. PubMed ID: 24923772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.